• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 3-乙酰基-2,5-二取代-1,3,4-恶二唑啉的生物活性、脂溶性和细胞毒性。

Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines.

机构信息

Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland.

Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.

出版信息

Int J Mol Sci. 2021 Dec 20;22(24):13669. doi: 10.3390/ijms222413669.

DOI:10.3390/ijms222413669
PMID:34948461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8704594/
Abstract

Antibiotic resistance is now a global problem, and the lack of effective antimicrobial agents for the treatment of diseases caused by resistant microbes is increasing. The 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines presented in this article may provide a good starting point for the development of potential new effective antimicrobial agents useful in the treatment of bacterial and fungal infections. Particular attention is drawn to the 1,3,4-oxadiazole derivative marked with the number with 5-nitrofuran-2-yl substituent in its chemical structure. This substance showed a strong bactericidal effect, especially against spp., and no cytotoxicity to the L929 normal cell line.

摘要

抗生素耐药性现在是一个全球性问题,而缺乏有效治疗耐药微生物引起的疾病的抗菌药物的情况正在加剧。本文介绍的 3-乙酰基-2,5-二取代-1,3,4-恶二唑啉可能为开发用于治疗细菌和真菌感染的潜在新型有效抗菌药物提供了一个良好的起点。特别值得注意的是,化学结构中带有 5-硝基呋喃-2-基取代基的 1,3,4-恶二唑啉衍生物。该物质对 spp. 表现出很强的杀菌作用,而且对 L929 正常细胞系没有细胞毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6038/8704594/6f2477887f43/ijms-22-13669-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6038/8704594/6f2477887f43/ijms-22-13669-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6038/8704594/6f2477887f43/ijms-22-13669-sch001.jpg

相似文献

1
Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines.新型 3-乙酰基-2,5-二取代-1,3,4-恶二唑啉的生物活性、脂溶性和细胞毒性。
Int J Mol Sci. 2021 Dec 20;22(24):13669. doi: 10.3390/ijms222413669.
2
Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity.新型 3-乙酰基-2,5-二取代-1,3,4-噁二唑啉的合成与生物活性。
Molecules. 2020 Dec 10;25(24):5844. doi: 10.3390/molecules25245844.
3
Synthesis and antimicrobial activity of some 5-aryl-2-[N,N-disubstituted thiocarbamoylthio)acylamino]-1,3,4-oxadiazoles.一些5-芳基-2-[[N,N-二取代硫代氨基甲酰硫基)酰基氨基]-1,3,4-恶二唑的合成与抗菌活性
Farmaco. 1998 Aug-Sep;53(8-9):541-4. doi: 10.1016/s0014-827x(98)00063-9.
4
Structure-activity relationship for the oxadiazole class of antibiotics.恶二唑类抗生素的构效关系。
J Med Chem. 2015 Feb 12;58(3):1380-9. doi: 10.1021/jm501661f. Epub 2015 Jan 30.
5
Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA).合成并评价新型 2-(噻唑-5-基)-1,3,4-恶二唑类衍生物库对耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌活性。
Bioorg Chem. 2020 Jan;94:103364. doi: 10.1016/j.bioorg.2019.103364. Epub 2019 Oct 18.
6
Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.新型对氨基苯磺酰基噁二唑类化合物作为潜在的膜活性抗菌药物,针对耐甲氧西林金黄色葡萄球菌。
Bioorg Med Chem Lett. 2021 Jun 1;41:127995. doi: 10.1016/j.bmcl.2021.127995. Epub 2021 Mar 26.
7
Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.1,2,4-恶二唑类抗生素构效关系的探索
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4854-4857. doi: 10.1016/j.bmcl.2015.06.044. Epub 2015 Jun 18.
8
Synthesis, molecular modeling and preliminary biological evaluation of a set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole as potential antibacterial, anti-Trypanosoma cruzi and antifungal agents.一组 3-乙酰基-2,5-二取代-2,3-二氢-1,3,4-噁二唑的合成、分子建模和初步生物学评价,作为有潜力的抗菌、抗 Trypanosoma cruzi 和抗真菌药物。
Bioorg Med Chem. 2011 Nov 1;19(21):6292-301. doi: 10.1016/j.bmc.2011.09.009. Epub 2011 Sep 10.
9
Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds.基于 6-氯-9-咔唑衍生物和 1,3,4-恶二唑骨架的新型抗菌剂的设计、合成及体外评价。
Molecules. 2020 Jan 9;25(2):266. doi: 10.3390/molecules25020266.
10
Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii.新型1,2,5-恶二唑的合成及其对鲍曼不动杆菌的作用评估。
Bioorg Med Chem. 2017 Dec 15;25(24):6267-6272. doi: 10.1016/j.bmc.2017.08.015. Epub 2017 Aug 10.

引用本文的文献

1
Synthesis, Characterization, Cytotoxicity Analysis and Evaluation of Novel Heterocyclic Derivatives of Benzamidine against Periodontal Disease Triggering Bacteria.新型苯甲脒杂环衍生物对引发牙周疾病细菌的合成、表征、细胞毒性分析及评价
Antibiotics (Basel). 2023 Feb 2;12(2):306. doi: 10.3390/antibiotics12020306.
2
Bioactive Oxadiazoles 2.0.生物活性噁二唑 2.0。
Int J Mol Sci. 2022 Mar 31;23(7):3841. doi: 10.3390/ijms23073841.

本文引用的文献

1
Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity.新型 3-乙酰基-2,5-二取代-1,3,4-噁二唑啉的合成与生物活性。
Molecules. 2020 Dec 10;25(24):5844. doi: 10.3390/molecules25245844.
2
Methicillin-resistant Staphylococcus aureus in Nepal: A systematic review and meta-analysis.尼泊尔耐甲氧西林金黄色葡萄球菌:系统评价和荟萃分析。
Int J Infect Dis. 2021 Feb;103:48-55. doi: 10.1016/j.ijid.2020.11.152. Epub 2020 Nov 18.
3
Heterocycle Compounds with Antimicrobial Activity.具有抗菌活性的杂环化合物。
Curr Pharm Des. 2020;26(8):867-904. doi: 10.2174/1381612826666200206093815.
4
First Report on Multidrug-Resistant Methicillin-Resistant Isolates in Children Admitted to Tertiary Hospitals in Vietnam.越南三省医院耐甲氧西林金黄色葡萄球菌耐药株的首次报告
J Microbiol Biotechnol. 2019 Sep 28;29(9):1460-1469. doi: 10.4014/jmb.1904.04052.
5
Synthesis and in Vitro Antimicrobial Activity Screening of New 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazoline Derivatives.新型3-乙酰基-2,5-二取代-1,3,4-恶二唑啉衍生物的合成及体外抗菌活性筛选
Chem Biodivers. 2019 Jun;16(6):e1900082. doi: 10.1002/cbdv.201900082. Epub 2019 May 3.
6
Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of Growth In Vitro via Structure-Based Design.基于结构设计发现具有强效和选择性的卤代咪唑硫代缩氨基脲类化合物,用于体外抑制 生长。
Molecules. 2019 Apr 24;24(8):1618. doi: 10.3390/molecules24081618.
7
Antimicrobial and anti-biofilm properties of novel synthetic lignan-like compounds.新型合成木脂素类化合物的抗菌和抗生物膜特性
New Microbiol. 2019 Jan;42(1):21-28. Epub 2019 Feb 20.
8
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.耐甲氧西林金黄色葡萄球菌:基础与临床研究概述。
Nat Rev Microbiol. 2019 Apr;17(4):203-218. doi: 10.1038/s41579-018-0147-4.
9
Emergence of Global Antibiotic Resistance.全球抗生素耐药性的出现
Prim Care. 2018 Sep;45(3):467-484. doi: 10.1016/j.pop.2018.05.006.
10
Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.1,3,4-噁二唑衍生物对金黄色葡萄球菌浮游细胞和生物膜的抗菌活性。
Future Med Chem. 2018 Feb;10(3):283-296. doi: 10.4155/fmc-2017-0159. Epub 2018 Jan 15.